Dillard’S, Inc.
—- Market cap
- —
- Debt
- +-$402.20M
- Cash
- −$861.46M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: DDS stock price vs AMRN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AMRN's multiple
Needs AMRN P/E.
Implied fair value · at DDS's multiple
Needs Annual EPS is negative, DDS P/E.
Metric by metric
Where each company leads, and how wide the gap is.
Price unavailable
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: DDS FY 2026 (ended Jan 31, 2026) · AMRN FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
DILLARD’S, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
AMARIN CORP PLC\UK · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
-0.23x
0.39x
Net debt / EBITDA
Leverage against operating earnings
-1.82x
3.79x
Cash and equivalents
Liquid reserves on the balance sheet
$861.46M
$302.59M
Total debt
Interest-bearing obligations outstanding
-$402.20M
$177.39M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Macy's, Inc.
DDS vs M
KOHLS Corp
DDS vs KSS
TJX COMPANIES INC /DE/
DDS vs TJX
NORDSTROM INC
DDS vs JWN
LIGAND PHARMACEUTICALS INC
DDS vs LGND
Harmony Biosciences Holdings, Inc.
DDS vs HRMY
SUPERNUS PHARMACEUTICALS, INC.
DDS vs SUPN
Viatris Inc
DDS vs VTRS
Organon & Co.
DDS vs OGN
INCYTE CORP
DDS vs INCY
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.